Kyntra Bio
Open
$7.19
Prev. Close
$7.19
High
$7.26
Low
$7.19
Market Snapshot
$28.52M
0.2
-11.84
$-96.77M
34
The company is headquartered in San Francisco, California. The company went IPO on 2014-11-14.
emptyResult
The company is headquartered in San Francisco, California. The company went IPO on 2014-11-14.
Recently from Cashu
Kyntra Bio's Innovation and Sustainability Strategy in Biotechnology Sector
Kyntra Bio's Strategic Positioning in the Biotech Landscape Kyntra Bio is poised to make significant strides within the biotechnology sector, particularly as advancements in gene editing and synthetic…
Kyntra Bio: Revolutionizing Biomanufacturing with Sustainability and Innovation in Life Sciences.
Kyntra Bio’s Innovative Approach to Biomanufacturing: A Game Changer in the Life Sciences Sector Kyntra Bio is at the forefront of revolutionizing biomanufacturing processes, a critical component in t…
Kyntra Bio's FG-3246 Trial Results Show Promise for Prostate Cancer Treatment Advancements
Kyntra Bio's Breakthrough in Prostate Cancer Treatment: FG-3246 Trial Results Hold Promise Kyntra Bio Inc., formerly known as Fibrogen, announces critical data from its Phase 1b/2 clinical trial inves…